- Home
- MAN vs SUPN Comparison
MAN vs SUPN Comparison
Compare MAN & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAN
- SUPN
- Stock Information
- Founded
- MAN 1948
- SUPN 2005
- Country
- MAN United States
- SUPN United States
- Employees
- MAN N/A
- SUPN N/A
- Industry
- MAN Professional Services
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- MAN Consumer Discretionary
- SUPN Health Care
- Exchange
- MAN Nasdaq
- SUPN Nasdaq
- Market Cap
- MAN 2.0B
- SUPN 1.9B
- IPO Year
- MAN 1988
- SUPN 2012
- Fundamental
- Price
- MAN $40.82
- SUPN $31.52
- Analyst Decision
- MAN Hold
- SUPN Hold
- Analyst Count
- MAN 5
- SUPN 2
- Target Price
- MAN $50.60
- SUPN $36.00
- AVG Volume (30 Days)
- MAN 779.6K
- SUPN 682.9K
- Earning Date
- MAN 07-17-2025
- SUPN 08-05-2025
- Dividend Yield
- MAN 5.60%
- SUPN N/A
- EPS Growth
- MAN 129.57
- SUPN N/A
- EPS
- MAN 2.33
- SUPN 1.11
- Revenue
- MAN $17,540,900,000.00
- SUPN $667,997,000.00
- Revenue This Year
- MAN N/A
- SUPN N/A
- Revenue Next Year
- MAN $2.56
- SUPN $12.02
- P/E Ratio
- MAN $17.35
- SUPN $28.62
- Revenue Growth
- MAN N/A
- SUPN 11.82
- 52 Week Low
- MAN $37.99
- SUPN $25.55
- 52 Week High
- MAN $78.22
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- MAN 47.61
- SUPN 43.52
- Support Level
- MAN $37.99
- SUPN $30.93
- Resistance Level
- MAN $40.09
- SUPN $31.76
- Average True Range (ATR)
- MAN 1.33
- SUPN 0.96
- MACD
- MAN 0.06
- SUPN -0.16
- Stochastic Oscillator
- MAN 51.52
- SUPN 24.04
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.